Discover how immunoprofiling is transforming head and neck cancer treatment by decoding the immune system's interaction with tumors and enabling personalized immunotherapy approaches.
Groundbreaking phase II trial shows engineered tumor cells can combat prostate cancer by transforming them into antigen-presenting cells.